SICRIPTIN 1.25 MG (Bromocriptine (1.25mg))

Sicriptin 1.25 mg Tablet is a pharmaceutical agent indicated for the management of elevated prolactin levels, certain cases of female infertility, and acromegaly, a condition characterized by excessive growth hormone. The mechanism of action involves the suppression of prolactin secretion, which is also known as the lactation hormone. In patients with acromegaly, this medication helps reduce the secretion of growth hormone. It is recommended to ingest Sicriptin 1.25 mg with food for optimal absorption and to maintain consistent dosing at the same time daily for improved efficacy. The precise dosage and frequency of administration will be tailored by your healthcare provider based on your specific condition and therapeutic needs. It is crucial to adhere strictly to the length of the treatment as prescribed. In conjunction with this medication, it is beneficial to engage in regular physical activity, adhere to a balanced diet, and continue any other diabetes medications as directed. Should any side effects occur, including but not limited to gastrointestinal disturbances or headaches, it is advisable to consult your physician for potential mitigation strategies. Additionally, it is prudent to keep glucose tablets on hand to address any occurrences of hypoglycemia. Avoiding alcohol is recommended, as it may exacerbate the side effects of this therapy.